Singapore: US Food and Drug Administration has approved Varubi (rolapitant), marketed by US based, to prevent delayed ph...
Singapore: Bristol-Myers Squibb has elected Dr Thomas J Lynch to the board, effective January 1, 2014. Dr Lynch will ser...
Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on...
Singapore: Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based China...
Singapore: Eisai has revealed therapeutic effects of lenvatinib (generic name- VEGF receptor tyrosine kinase inhibitor a...
The product is ready for Day 1 launch, said Strides in a press release. Dutasteride is used to treat benign prostatic h...
Singapore: Eisai published the results of its 'adjunctive perampanel for refractory partial-onset seizures: randomized p...
Singapore: Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline...
Singapore: Taiwan's PharmaEngine has filed a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA...
Singapore: AOP Orphan, a pharmaceutical company in the field of rare diseases, has launched world's first drug approved ...
Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly...
Tokyo: PeptiDream Inc., a Tokyo-based biopharmaceutical company, has signed a multi-target discovery and optimization co...
Singapore: 3SBio, China-based biotechnology company focused on researching, developing, manufacturing and marketing biop...
Singapore: US based Roivant Neurosciences, a biopharmaceutical company engaged in the development and commercialization ...
Singapore: Korea based ImmunoMet Therapeutics, a biotechnology company developing innovative drugs for the treatment of ...
Bangalore: AstraZeneca and Cellworks have announced a collaboration, to speed the design of novel combination therapies ...
Singapore: Researchers from the University of Queensland in Australia have identified that existing drugs could be repur...
Singapore: Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cance...
